Abilify Mycite(Aripiprazole)
4578.T
Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Otsuka Holdings Co., Ltd.
$90K
Medicare cost, 2024
$90K
Medicare cost, 2024
Medicare drug plans spent $90,322 on Abilify Mycite (aripiprazole) in 2024, for 53 prescriptions and refills filled by 16 patients. Spending rose 20% from 2023 to 2024. It is made by Otsuka Holdings Co., Ltd. (4578.T).
Medicare cost, 2024
$90K
+19.8% from 2023
Prescriptions
53
$1,704.20 per claim
Patients
16
11 prescribers
Total spending, 2024
$90K
$5,645.15 per patient
Questions and answers
How much does Medicare spend on Abilify Mycite?
Medicare prescription drug plans paid $90K for Abilify Mycite in 2024, for 53 prescriptions and refills to 16 patients (up 19.8% from 2023). The average cost per claim was $1,704.20.
Which state spends the most on Abilify Mycite?
California had the highest Medicare cost for Abilify Mycite in 2024: $42K for 25 claims.
Who prescribes Abilify Mycite the most?
Douglas Sears, specialist in Encino, CA, had the highest Medicare cost for Abilify Mycite in 2024: 25 claims costing $42K.
Who makes Abilify Mycite?
Abilify Mycite is made by Otsuka Holdings Co., Ltd. (4578.T), listed in the Medicare spending data as Otsuka America.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Abilify Mycite was $90K in 2024, after a high of $92K in 2020.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Abilify Mycite, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Douglas Sears Encino, CA | Specialist | 25 | Under 11 | $42K |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 7 | 44 | - | $76K |
| 2023 | 8 | 44 | - | $75K |
| 2024 | 11 | 53 | 16 | $90K |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Otsuka America | 53 | $90K |
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 123,305 side-effect reports named aripiprazole, the active ingredient of Abilify Mycite (reports from 2003 on). 82,473 of them (66.9%) were serious, 6,865 named a death and 36,534 named a hospital stay. The reactions named most often were drug ineffective, weight increased and off label use. 30,262 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
123,305
5,881 in 2025 (-12.5% from 2024)
Serious
66.9%
82,473 reports
Deaths named
6,865
5.6% of reports
Hospital stays
36,534
29.6% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Abilify Mycite?
123,305 reports from 2003 through September 2026 named aripiprazole, the active ingredient of Abilify Mycite. 82,473 of them (66.9%) were serious, 6,865 named a death and 36,534 named a hospital stay.
What are the most reported side effects of Abilify Mycite?
8,507 reports named drug ineffective, the reaction named most often, followed by weight increased (7,919) and off label use (7,695). In the last 5 years the reaction named most often was drug ineffective (2,988 reports). A report can name several reactions.
How many side-effect reports named Abilify Mycite in 2025?
5,881 reports were received in 2025 (-12.5% from 2024). 2026 so far: 4,853 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Abilify Mycite caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Abilify Mycite caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with aripiprazole: Abilify Maintena, Aripiprazole, Abilify Asimtufii, Aripiprazole Odt, Abilify
- Makers on the stock market:
4578.T·4578.T drug pipeline - Drug approvals (27 approvals on file for aripiprazole) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (aripiprazole) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.